Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved UPLIZNA® (inebilizumab-cdon) for the treatment of generalized myasthenia gravis (gMG) in adults who ...
The 5 most innovative tech products we tested this year (including a tri-fold surprise) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback